Kendra Goldhirsch is an Associate at the Firm. Ms. Goldhirsch is a 2015 New York Metro Super Lawyers Rising Star. Her practice focuses on national product liability litigation and mass torts.
A Virginia woman has joined the Xarelto multidistrict litigation in the Eastern District of Louisiana. She filed her case on March 20, 2017, and claims that her husband suffered serious injuries and died after taking Xarelto. She seeks $2 million in damages. Man Suffers from…
Medical device manufacturer Olympus America recalled its controversial TJF-Z180V duodenoscope in January 2016 to update it with a new design and new labeling. The changes were taken after reports linked the duodenoscopes to serious “superbug” bacterial infections in patients. The new design and lab
The FDA recently warned women and their healthcare providers on March 21, 2017, of a potential cancer risk associated with breast implants. They noted that since 2011, they had received hundreds of reports of breast-implant-related anaplastic large cell lymphoma (ALCL), a rare type of blood…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits in one court in the Eastern District of Louisiana. Since then, both sides have been working toward preparing a small number of cases for bellwether trials to gauge…
On April 5, 2017, the FDA announced a worldwide recall of about 14,000 Medtronic Newport HT70 and Newport HT70 Plus ventilators manufactured since 2010. The manufacturer recalled these devices because of reports showing that the ventilator may reset during normal operation without an alarm warning.…
A Texas man filed a new lawsuit against Bristol-Myers Squibb and Pfizer, Inc., manufacturers of the blood-thinning drug Eliquis. He filed as Personal Representative of his wife’s Estate, whom he claims passed away as a result of taking Eliquis. The case was filed on March…
If you’re over the age of 60, you’ve probably been told that it’s time to start thinking about the shingles vaccine, Zostavax. This vaccine is intended to help reduce the risk of shingles. For those who develop the condition despite being immunized, Zostavax may help…
According to the FDA, if you have gone through a surgical procedure to remove your gallbladder, you shouldn’t be using Viberzi (eluxadoline), a prescription drug treatment for irritable bowel syndrome (IBS). In a recent drug safety communication, the FDA warned that Viberzi can increase the…
According to a recent FDA safety update, as of February 1, 2017, the administration had received 359 medical device reports (“MDR”) of a rare type of non-Hodgkin’s lymphoma related to breast implants. Nine of those reports involved patient deaths. This is the same cancer that…
The anticoagulant drug Xarelto (rivaroxaban) is currently the subject of over 15,000 personal injury lawsuits pending in the Eastern District of Louisiana in a consolidated MDL litigation. Plaintiffs in these suits allege that after taking the drug, they suffered excessive bleeding events, and seek
In October 2016, Eliquis manufacturers Bristol-Meyers Squibb and Pfizer Inc. submitted a petition to the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all Eliquis lawsuits into one court for pre-trial proceedings. They argued at the time that coordination would serve the conv
Right now, if something goes wrong with a medical device like a hip replacement system, diagnostic tool, or surgical device, patients, doctors, hospitals and medical centers are supposed to report it through the FDA’s adverse event reporting system. Critics have reported that this system is…